Related Experiment Video
Updated: Feb 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetic ketoacidosis, hyperuricemia and encephalopathy intractable to regular-dose insulin
Insights
Diabetic ketoacidosis (DKA) is rare in infants. This case highlights the importance of considering rasburicase for infants with DKA and hyperuricemia, especially when metabolic acidosis is severe and refractory.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Diabetic ketoacidosis (DKA) is uncommon in infants under one year.
- Typical DKA presentation involves weight loss and polyuria, progressing to symptomatic acidosis.
Observation:
- An infant presented with constipation, abdominal pain, lethargy, dehydration, and profound encephalopathy.
- Initial labs showed severe metabolic acidosis (pH 6.9), hyperglycemia (>700 mg/dL), leukocytosis (77 K/μL), and hyperuricemia (15.9 mg/dL).
- Despite standard DKA treatment (fluids, insulin), the infant's condition, including metabolic acidosis and altered mental status, did not improve.
Findings:
- The infant required rasburicase and broad-spectrum antibiotics due to refractory shock and acidosis.
- Increased insulin infusion and rasburicase administration were necessary.
- A hemoglobin A1C of 7.4 solidified the diagnosis of DKA.
Implications:
- Metabolic acidosis in infants necessitates a broad differential diagnosis.
- Rasburicase is a potential therapeutic consideration for infants with DKA and hyperuricemia, particularly in refractory cases.
Background:
Diabetic ketoacidosis (DKA) in children less than 1 year of age is a rare occurrence. Typical presentation includes a prodrome of weight loss and polyuria with subsequent presentation to medical care when acidosis becomes symptomatic.
Case Presentation:
We describe an unusual case of a previously healthy infant with a 3 days' history of constipation, presenting acutely with abdominal pain, lethargy, and dehydration. On initial evaluation, our patient had profound encephalopathy, with marked tachypnea and work of breathing. Arterial blood gas revealed a pH of 6.9, pCO2 of 20 and a bicarbonate level of <5. There was profound leukocytosis (WBC 77 K/μL), hyperuricemia (uric acid 15.9 mg/dL), and evidence of pre-renal azotemia [blood urea nitrogen (BUN) 54, Cr 0.82]. Blood glucose was >700 mg/dL. Despite fluid resuscitation and insulin infusion of 0.1 unit/kg/h, which are the mainstays of therapy for DKA, her severe metabolic acidosis and altered mental status did not improve. Differential diagnosis for her metabolic derangements included inborn errors of metabolism, insulin receptor defects, toxic ingestions, and septic shock secondary to an underlying oncologic or intra-abdominal process. The patient was treated with broad spectrum antibiotics and rasburicase. She continued to have significant shock for the first 30 h of her hospital stay, requiring moderate vasoactive support. Due to her refractory acidosis and persistent hyperglycemia, insulin infusion was increased to 0.15 units/kg/h. A hemoglobin A1C obtained on the second hospital day revealed a level of 7.4 and helped to solidify the diagnosis.
Conclusions:
Metabolic acidosis in an infant requires a broad differential. Rasburicase should be considered in hyperuricemia and DKA.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Chronic Kidney Disease II: Clinical Manifestations
Inborn Errors of Metabolism
Hypoglycemia and Glucagon
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Diabetes: Symptoms, Diagnosis, and Complications

